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Introduction
Some bacteria exert their pathogenic effects by producing toxins.
Some toxins are responsible for all the symptoms observed
in the natural disease, such as paralytic syndrom caused by
Clostridium tetani and Clostridium botulinum neurotoxins or
diarrhea induced by Clostridium difficile toxins. 
Bacterial toxins interact with cells in various ways. Some
toxins bind to a cell surface receptor and induce a signal through
the membrane, some form pores in the membrane and others
are internalized by endocytic vesicles and modify a cytosolic
target. A large number of internalized toxins recognize the actin
cytoskeleton. Some toxins interact directly with actin
monomers, and others modify a regulatory protein from the
Rho family. Most of these toxins are produced by anaerobic
bacteria from the Clostridium genus, which mostly cause
gastrointestinal diseases and gangrene. Perturbation of the actin
cytoskeleton induces changes in cell morphology and various
functions such as motility, cytokinesis, exocytosis, endocytosis
and increases epithelium and endothelium permeability.
Toxins active against actin monomers
The toxins of this group disturb the actin cytoskeleton by
directly modifying actin monomers. They include C. botulinum
C2 toxin, Clostridium perfringens Iota toxin, Clostridium
spiroforme toxin and C. difficile transferase (CDT) (Table 1).
These toxins are involved in gastrointestinal diseases in animals
and, less frequently, in humans.
C2 toxin is produced by C. botulinum types C and D, which
also synthesize the neurotoxins C1 and D respectively,
responsible for animal botulism. C2 toxin is an enterotoxin and
causes hemorrhagic and necrotic lesions, which are often
observed in the intestinal wall of birds and cattle that have died
from botulism. In addition, in experiments, C2 toxin has been
shown to induce hemorrhagic enteritis in mice.
C. perfringens E synthesizes Iota toxin and is associated
with enterotoxemia in calves. Toxigenic C. spiroforme are
the etiological agents of enteritis in rabbit and some cases
have been described in humans. Certain C. difficile strains
produce, in addition to toxins A (ToxA) and B (ToxB), an
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Bacterial toxins modifying the actin
cytoskeleton
Summary Numerous bacterial toxins recognize the actin cytoskeleton as a target.
The clostridial binary toxins (Iota and C2 families) ADP-ribosylate the actin monomers
causing the dissociation of the actin filaments. The large clostridial toxins from
Clostridium difficile, Clostridium sordellii and Clostridium novyi inactivate, by
glucosylation, proteins from the Rho family that regulate actin polymerization. In
contrast, the cytotoxic necrotic factor from Escherichia coli activates Rho by
deamidation and increases the formation of actin filaments. The enterotoxin of
Bacteroides fragilis is a protease specific for E-cadherin and it promotes the
reorganization of the actin cytoskeleton. The bacterial toxins that modify the actin
cytoskeleton induce various cell disfunctions including changes in cell barrier
permeability and disruption of intercellular junctions.
Key words Toxins · Actin · Rho proteins · Ras proteins · Intercellular junction
ADP-ribosyltransferase called CDT whose role in disease
is unknown.
The actin modifying toxins are binary toxins (Fig. 1). They
consist of two independent proteins not linked by covalent or
disulfide bonds, and are encoded by two genes. The binding
components (C2-II for C2 toxin, Ib for Iota toxin, Sb for 
C. spiroforme toxin, and CDTb for CDT) are synthesized as
a precursor protein (90–100 kDa) that requires the proteolytic
cleavage of a 20 kDa N-terminal peptide to be active. The
active binding components recognize a cell surface receptor
that has not yet been identified, and mediate the internalization
of the enzymatic components (C2-I for C2 toxin, Ia for Iota
toxin, Sa for C. spiroforme toxin, and CDTa for CDT) into the
cells. The whole toxin is internalized into endocytic vesicles
and the enzymatic component is then delivered to the cytosol.
The enzymatic components catalyze the ADP-ribosylation
of G-actin monomers, but not F-actin, at Arg-177. The actin
in cells is in dynamic equilibrium between G-actin monomers
and actin filaments. The filaments polymerize at one end (fast
growing end or barbed end) and depolymerize at the other (slow
growing end or pointed end). The ADP-ribosylated actin
monomers bind to the fast growing ends of actin filaments and
inhibit actin polymerization by preventing the incorporation
of further actin monomers, in a manner similar to that of capping
proteins. The acceptor amino acid (Arg-177) is located in
domain III of actin, which is involved in actin monomer
recognition. In contrast, activity at the slow growing ends is
not modified, and depolymerization leads to a complete
dissociation of the actin filaments. In addition, ADP-ribosylation
inhibits actin ATPase activity. The loss of actin microfilaments
induces morphological changes (cell rounding and detachment
from the support) and alterations in cellular functions dependent
on the actin cytoskeleton [1, 43].
The clostridial actin-ADP-ribosylating toxins have a
common structure, but differ immunologically and in biological
activity. They can be divided into two families, one corre-
sponding to the C2 toxin of C. botulinum (C2 family), and the
other to the C. perfringens Iota toxin, C. spiroforme toxin and
C. difficile transferase (Iota family) [37, 38].
The toxins of the Iota family are immunologically related
and display 77–82% amino acid sequence identity (Table 1).
Moreover, the binding and enzymatic components can be
interchanged to form a toxin that is fully active in cell rounding
and is lethal to mice. For example, the binding components Ib
and Sb can mediate the internalization and cytotoxicity of CDTa.
In contrast, the toxins from the two families are unrelated,
or only weakly related, and no functional complementation
between the components of each family has been demonstrated.
Therefore, the binding components of the Iota family cannot
translocate the enzymatic components of C2 toxin or vice versa.
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Table 1 Toxins acting on the actin cytoskeleton and enzymatic activities. Amino acid sequence identity was determined by the Gap program from the Genetics
Computer Group package
Toxin and microorganisms Amino acid sequence identity Enzymatic activity Cofactor Substrate1
Binary toxins
C2 family ADP ribosylation NAD
C. botulinum C and D β/γ G-actin (Arg177)
Iota family
C. perfringens Iota αβγ G-actin (Arg177)
C. spiriforme toxin
C. difficile CDT
C3 enzymes ADP ribosylation NAD Rho (Asn41)
C. botulinum D (1873)
C. botulinum C (006)
C. limosum
S. aureus
Bacillus cereus
Large clostridial toxins
C. sordellii LT82 UDP-glucose Ras (Thr35), Rac, Rap, Ral
C. sordellii LT9048 UDP-glucose Ras, Rac, CDC42
C. sordellii HT Glucosylation UDP-glucose Rho (Thr37), Rac, CDC42 (Thr35)
C. difficile ToxB UDP-glucose Rho (Thr37), Rac, CDC42 (Thr35)
C. difficile F ToxB UDP-glucose Rac
C. difficile ToxA UDP-glucose Rho (Thr37), Rac, CDC42 (Thr35)
C. novyi Toxin α UDP-N-acetyl- Rho (Thr37), Rac, CDC42 (Thr35)
glucosamine
Rho-activating toxins
E. coli CNF1 Deamidation Rho (Gln63), Rac, CDC42
CNF2
Bordetella Rho (Gln63)
bronchiseptica DNT
Proteolytic enterotoxin
Bacteroides Proteolysis E-cadherin
fragilis BFT
1Amino acids in brackets indicates the site of modification.
29–41%
72–82%
66%
63%
36%
76%
48%
32%
85%
32%
The binary toxins are internalized into cells by receptor-
mediated endocytosis. However, the binding components of
C2 and Iota toxins recognize different receptors which have
not yet been identified. C2 toxin enters via acidic endocytic
vesicles, whereas toxins of the Iota family enter via non-acidic
endosomes [39]. The intracellular targets of the enzymatic
components are also different. Iota toxin is able to modify all
actin isoforms (muscular and non-muscular actin), whereas C2
toxin only ADP-ribosylates β/γ cytoplasmic and γ smooth
muscle actin [1].
The binding components of the Iota family are significantly
similar (34–38% sequence identity) to the protective antigen
(PA) of the anthrax toxins. The anthrax toxins are also binary
toxins consisting of 3 independent proteins. PA is the binding
component and can mediate the internalization into cells of the
edema factor (EF) or the lethal factor (LF), the enzymatic
components active within cells. These binding components are
proteolytically split into 3 fragments, signal peptide 
(29 N-terminal residues), propeptide (20 kDa) and mature
protein (74–80 kDa). The PA crystal structure comprises 4
domains. Activation by furin releases the 167 N-terminal
residues (propeptide) of domain 1, and residues 168–258
(domain 1´) form a hydrophobic surface that is thought to be
the binding site for EF and LF. Domain 2 contains a β-barrel
core and a large flexible loop involved in membrane insertion.
The function of the small domain 3 is unknown. Domain 4,
which is located in the C-terminal part and contains a 
β-sandwich, is involved in the recognition of the cell surface
receptor [40]. The corresponding amino acid sequences of the
binding components of the clostridial binary toxins are
significantly similar (30–43% identity) to domains 1 to 3 of
PA, indicating that these components have a conserved structure
and similar folding. The low homology (less than 10% identity)
between domain 4 of PA and the corresponding sequences of
the binding components of clostridial binary toxins reflects the
fact that different receptors recognized by each component.
The active site has been mapped to the C-terminal part of
the enzymatic components, and is similar to that in other 
ADP-ribosylating toxins. The active site consists of a 
NAD-binding cavity, composed of a β-strand and an α-helix
flanked by two residues important for catalytic activity (Arg
or His, and Glu) [6]. The residues (STS(I/L)) forming the 
β-strand are highly conserved in the enzymatic components
and also in C3 enzymes, cholera toxin, Escherichia coli heat
labile toxin and pertussis toxin, whereas those involved in
the α-helix are less conserved [15]. The flanking residues 
(Arg-295, Glu-378 and Glu-380) of Ia, which are conserved in
all the enzymatic components of the actin ADP-ribosylating
toxins, have been identified by site directed mutagenesis as
essential for enzymatic activity [36]. The mutated proteins,
when introduced into Vero cells in the presence of Ib, were not
cytotoxic, confirming that the intracellular ADP-ribosylation
of actin is responsible for the cytotoxic effects of Iota toxin.
Actin ADP-ribosylating toxins have a biglutamic motif (Glu-
378-X-Glu-380) that is probably involved in NAD binding and
in the catalytic reaction, whereas in other ADP-ribosylating
toxins, the equivalent residues are Gln-X-Glu [36]. Similar
results have been reported for C2-I [2].
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Fig. 1 Structure of toxins modifying the actin cytoskeleton. The residues indicated correspond to the amino acids involved in the enzymatic site
Toxins modifying proteins regulating
actin assembly
In response to environmental signals, cells regulate their shape,
adhesion and motility by modification of the actin cytoskeleton.
External signals that trigger actin assembly and disassembly
act through various plasma membrane receptors and signal
transduction pathways including Rho-family proteins from the
Ras GTPase superfamily. Rho proteins act as molecular switches;
they are active in GTP-bound forms and inactive if linked to GDP.
The inactive state is stabilized by complex formation with
nucleotide dissociation inhibitor (GDI). GTPases are activated
by GDP-GTP exchange, which is promoted by guanine
nucleotide exchange factors (GEF) and ERM proteins (ezrin,
radixin, and moesin). In the activated state, GTPases interact
with many effectors to induce a coordinated cellular response.
GTPases return to the inactive state by hydrolysis of GTP,
mediated by GTPase activating protein (GAP) (Fig. 2).
Rho proteins control various aspects of actin organization.
Rho induces the assembly of actin-myosin filaments (stress
fibers) and of associated focal adhesion complexes. Rac
promotes actin polymerization at the cell periphery to form
lamellipodia and ruffles, whereas CDC42 is responsible for the
formation of filopodia or microspikes.
More than eight target protein kinases have been identified
for each of the GTPases of the Rho family, but the function of
only a few is known. Rho-kinase (RhoK) is activated by binding
to RhoGTP and increases the myosin light chain phospho-
rylation by inhibiting myosin light chain phosphatase, leading
to myosin filament assembly and F-actin bundling. The lipid
kinase, phosphatidylinositol-4-phosphate-5-kinase (PI4P5K),
is likely to be a central target of Rac and to a lesser extent, of
Rho. PI4P5K increases the synthesis of phosphatidylinositol
4,5-biphosphate (PIP2) which is known to increase actin
polymerization by release of capping proteins from the barbed
ends of actin filaments. N-WASP has been identified as an
effector of CDC42, involved in filopodium formation [17, 28,
29, 54, 58].
Rho proteins are also involved in gene transcription and
cell cycle progression. Rac and CDC42 can activate the c-
Jun and P38 mitogen-activated-protein kinase pathway, but the
mechanism is unclear [17, 29, 54].
C3 and C3-like enzymes C3 enzyme was originally described
in C. botulinum C and D. Two types of C3 gene have been
characterized, both encoding basic proteins (pI around 10) of
23.5 kDa with 66% amino acid sequence identity. The C3
genes are part of a transposon structure (21.5 kb) located on
phage DNA, which also contains the neurotoxin genes in 
C. botulinum C and D [18, 32, 43]. C3-like enzymes have also
been identified in Clostridium limosum, Bacillus cereus and
Staphylococcus aureus (Table 1) [1].
C3 enzyme is an ADP-ribosyltransferase smaller than the
enzymatic component of the actin-ADP-ribosylating toxins 
(Fig. 1). No binding component has been found for C3 enzyme,
which therefore does not efficiently enter cells. This enzyme
seems to correspond to the enzymatic component of 
ADP-ribosylating toxins (23% amino acid sequence identity)
lacking the machinery for cell internalization. The active site is
located in the C-terminal part of the molecule and is related to
that of actin ADP-ribosylating toxins and other ADP-ribosylating
toxins. The conserved β-strand and α-helix forming the NAD
cavity are flanked by the catalytic residues Arg-89 and Glu-174.
C3 enzyme specifically modifies Rho proteins at Asn-41.
This residue is located on switch I of small GTPases, the
conformation of which changes depends on the bound
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Fig. 2 Rho cycle and interaction
with toxins. Rho is inactive in the
GDP-bound form, and active in the
GTP-bound form. The flexible parts
of the molecule according to the
bound nucleotide are called switch
I, which is involved in the
recognition of the effector, and
switch II, which supports GTPase
activity. C3 and ToxB modify
residues of switch I and inactivate
Rho, whereas CNF and DNT act on
Gln-63 in switch II, inhibiting
GTPase activity and resulting in
permanently active Rho. GDI,
guanine nucleotide inhibitor; GEF,
guanine nucleotide exchange factor;
GAP, GTPase-activating protein;
ERM, ezrin, radixin and moesin;
RTK, tyrosine kinase receptor
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nucleotide, and which is the domain interacting with the effector.
Rho is only ADP-ribosylated by C3 if it is dissociated from
the guanine nucleotide dissociating factor (GDI). ADP-
ribosylation of Rho does not modify GTPase activity and does
not affect binding with effectors such as protein kinase N [52].
The inactivation of Rho by C3 involves the inhibition of
translocation of Rho to the membrane, which seems to be
mediated by the association of Rho, via the insert helix, with
a membrane-bound effector and the insertion of the prenylated
C-terminus into the lipid bilayer [11].
Rho ADP-ribosylated by C3 is inactivated causing the
disorganization of actin filaments (Fig. 2). The actin filaments
are depolymerized and only patches corresponding to short actin
filaments are detectable by immunofluorescence (Fig. 3A).
Large clostridial toxins The large clostridial toxins group
includes the largest bacterial toxins (250–300 kDa). They are
produced by Clostridium involved in gastrointestinal diseases
and gangrene (Table 1). 
C. difficile is responsible for pseudomembranous colitis
and about 30% of the postantibiotic treatment diarrhea common
in hospitalized patients. This microorganism produces two
toxins: an enterotoxin or toxin A (ToxA) and a very potent
cytotoxin or toxin B (ToxB).
C. sordellii is involved in gangrene in humans and animals,
hemorrhagic enteritis in cattle and enterotoxemia in sheep. This
microorganism also produces two toxins, a lethal toxin (LT)
which is closely related to ToxB (88% amino acid sequence
identity and immunological cross reactions between the two
toxins) and a hemorrhagic toxin (HT).
C. novyi is an etiological agent of gangrene with major
edema. The main toxin produced is the alpha toxin.
The large clostridial toxins have a common structure 
(Fig. 1). The C-terminal part, about 25–30% of the molecule,
contains repeats of 20–50 amino acids which are related to
those in glucosyltransferases produced by other bacteria such
as Streptococcus [57]. This domain is involved in the binding
to cell surface receptor. Therefore, polyclonal and monoclonal
antibodies specific for this domain neutralize the cytopathic
effects. It has also been found that recombinant amino acid
repeats block the binding of ToxA to the cell surface. A
trisaccharide motif has been found to bind to ToxA, and cells
bearing this structure are highly sensitive to ToxA [55]. In rabbit
ileum, the cell surface receptor of ToxA has been reported to
be the glycoprotein sucrase-isomaltase [44]. The receptors for
the other large toxins are not known.
The central part contains a hydrophobic region with a short
predicted transmembrane segment in all of the large clostridial
toxins. Comparison with other toxins, such as diphtheria toxin,
suggests that this central domain is probably involved in the
translocation of the active domain into the cytosol.
The binding site for the small GTPases and the enzymatic
site are located in the N-terminal part. Residues 1–546 in ToxB
(2366 amino acids) and LT (2364 amino acids) retain enzymatic
activity in vitro and are cytotoxic on microinjection [4, 21]. Region
364–516 determines substrate specificity. It seems that residues
364–468 are important for the recognition of Rho family proteins,
and residues 468–516 are involved in the recognition of Ras
proteins [20]. As reported for various glucosyltransferases, the
large clostridial toxins have a common DXD motif that is essential
for enzymatic activity. Replacement of Asn-286 and Asn-288 by
Ala in LT induces a dramatic decrease in glucosyltransferase
activity and binding of UDP-glucose. The DXD motif may be
involved in the coordination of divalent cations, which is required
for enzymatic activity, or in the binding of UDP-glucose [4]
The large clostridial toxins modify various small GTPases
by monoglucosylation. ToxA and ToxB from C. difficile and
alpha-toxin from C. novyi glucosylate proteins from the Rho
family (Table 1). ToxA and ToxB use UDP-glucose to transfer
the glucose moiety to Thr-37 in Rho and to the equivalent
position (Thr-35) in Rac and CDC42. Alpha-toxin recognizes
the same target proteins but catalyzes a slightly different reaction
consisting of the transfer of N-acetylglucosamine from 
UDP-N-acetylglucosamine to Rho proteins. Thr-37 is part of
switch I of Rho proteins and binds the nucleotide through the
coordination of Mg2+ [52]. 
ToxA, ToxB and alpha-toxin induce actin cytoskeleton
changes involving the loss of stress fibers and reorganization
of cortical actin. The cells become rounded and retraction
filaments are apparent (Fig. 3A).
LT is highly related to ToxB and is also a mono-
glucosyltransferase using UDP-glucose as cosubstrate. 
LT modifies Rac from the Rho family, CDC42 is also modified
by LT in certain strains. In addition, LT glucosylates GTPases
from the Ras family including Ras, Rap and Ral (Table 1).
LT induces actin cytoskeleton changes different from those
obtained with C. difficile toxins. The cells have an irregular
outline, lose of stress fibers, and undergo reorganization of cortical
actin, with numerous microspikes rich in actin and fimbrin [42].
In 3T3 cells, the glucosylation of Ras by LT at Thr-35
inhibits the stimulation of the MAP kinase cascade induced by
growth factors [42]. LT modifies Ras in the GDP-bound form.
Intrinsic and stimulated GTPase activity is decreased and the
interaction of modified Ras with its effector Raf is completely
inhibited, leading to blockade of the MAP kinase cascade [19].
In contrast, the MAP kinase pathway is not blocked by LT in
Xenopus oocytes. In these cells, LT induces cdc2 kinase
activation and germinal vesicle breakdown [45].
Necrotizing toxins Certain E. coli strains isolated from humans
and animals with diarrhea or extraintestinal infections, produce
a cytotoxic necrotizing factor (CNF) that causes multinucleation
in cultured cells and necrosis in rabbit skin. CNF1 is produced
by strains isolated from humans and animals, and CNF2 is
produced by E. coli strains isolated from cow and sheep. The
two toxins are similar in size (115 kDa), are immunologically
related and share 85% amino acid sequence identity [35]. CNF1
is chromosomally encoded and CNF2 is plasmid encoded.
CNFs are synthesized without a signal peptide. The catalytic
domain has been identified in the C-terminal part (amino acids
720–1007). The central part which contains a putative membrane-
spanning segment, is probably involved in the translocation of
the toxin into the cytosol, and the 299 N-terminal amino acids
are responsible for binding to a cell surface receptor (Fig. 1) [26].
CNFs induce a large increase in cell volume and actin
filaments. The cells become spread on the substrate and
flattened, with numerous ruffles on the surface and thickened
stress fibers. The increase in polymerized actin has been found
to be mediated by Rho [8]. 
The enzymatic activity of CNFs has recently been
elucidated. CNFs catalyze the deamidation of Rho Gln-63 to
give glutamic acid. This reduces the electrophoretic mobility
of Rho on gels. Gln-63 is located in switch II of Rho, which is
involved in GTPase activity. Therefore, Rho modified by CNFs
is permanently active due to the loss of intrinsic and Rho-GAP-
stimulated GTPase activity. This prevents the transition of Rho-
GTP into the GDP steady-state form (Fig. 2) [9, 48].
Bordetella bronchiseptica, responsible for swine atrophitic
rhinitis, produces a toxin called dermonecrotizing toxin (DNT),
which is related to CNFs. DNT also acts by deamidation of
Gln-63 in Rho [22].
A toxin acting on cadherin
Bacteroides fragilis strains associated with diarrheal diseases in
young animals and children have been found to produce an
enterotoxin called B. fragilis toxin (BFT). Two types of bft gene
have been characterized and encode proteins with an overall
amino acid sequence identity of 92% [10, 23]. The bft genes are
part of a 6 kb pathogenicity island in B. fragilis [30].
BFT is synthesized as an inactive protoxin secreted by
means of a signal peptide (18 N-terminal amino acids). The
precursor is processed proteolytically, to release the 211 
N-terminal residues. The resulting C-terminal 186 residues
(20.7 kDa) constitute the active form (Fig. 1) [10, 23].
BFT is cytotoxic for cultured cells such as HT29 and induces
cell rounding, swelling, and redistribution of F actin with the
loss of stress fibers and condensation of actin filaments in a
peripheral ring around the cell [24, 47]. BFT seems to be active
outside cells without requiring internalization because the
known inhibitors of endosomal and Golgi trafficking do not
prevent the effects of the toxin [47]. The C-terminal part
contains a predicted amphipathic region of 20 residues which
may be involved in the insertion of BFT multimers into the cell
membrane. Possible pore formation has not been demonstrated
experimentally [10]. 
The BFT sequence shows the presence of a zinc-binding
motif (HExxH) characteristic of zinc metalloproteases.
Although BFT is able to cleave G-actin in vitro, neither the
proteolysis of actin components nor a decrease in F actin
content have been observed in cells [46]. Recently, it has
been found that BFT cleaves E-cadherin specifically and may
induce a rearrangement of β-catenins leading to
reorganization of the actin cytoskeleton [57]. 
Effects of toxins altering the actin
cytoskeleton on cell functions
The inactivation of small G proteins and the disassembly of
the actin cytoskeleton impair various cell functions and tissue
organization.
Increase in cell barrier permeability One of the main
functions of epithelial and endothelial tissues is to control
the permeability between the two biological compartments that
regulate their composition. Of the four classes of intercellular
junction (tight junctions, adherence junctions, desmosomes
and gap junctions), tight junctions are the most critical in
limiting paracellular fluxes. Tight junctions consist of
transmembrane proteins (occludin and claudin) connecting
adjacent cells. Occludin is linked at the cytosolic sites of tight
junctions to zonula occludens proteins (ZO1, ZO2 and ZO3)
which are linked to actin filaments [12].
The integrity of the actin cytoskeleton has a crucial role in
the assembly of the tight junctions and the regulation of barrier
permeability. Cytochalasin D, which impairs actin filament
polymerization, has been found to increase paracellular
permeability in CaCo-2 cell monolayers [27]. Toxins that
directly act on actin monomers and disassemble actin filaments
induce similar effects. Therefore, Iota toxin markedly alters
monolayer permeability and ZO1 organization (Fig. 3B).
Rho and Rac are required for the establishment of tight
junctions and adherence junctions mediated by cadherin [3, 16,
53]. Toxins that modify Rho and/or Rac increase cell barrier
permeability and alter the organization of the tight junctions
detected by the disruption of ZO1 immunostaining (Fig. 3B). 
C3 enzyme preferentially alters actin filament organization in the
apical pole and the associated tight junction of polarized intestinal
epithelial cells [33]. ToxB and ToxA are also very potent toxins
that alter cell barrier permeability [41]. In contrast, LT does not
significantly disorganize ZO1 organization in CaCo-2 cells 
(Fig. 3B). The effects of toxins modifying the actin cytoskeleton
on the intermediate junctions involve the reduction of the intensity
of labeling with anti-cadherin antibodies (Fig. 3C).
In polarized T84 and MDCK cells, BFT induces a marked
decrease in cell barrier permeability if applied to the basolateral
side. The effects are less pronounced if the toxin is applied to
the apical side. Upon basolateral application, BFT induces a
loss of microvilli and F actin filaments at the apical side and
an increase in actin filaments at the basal pole, accompanied
by the disruption of tight junctions [5, 34]. BFT also seems
to stimulate Cl– secretion in T84 monolayers [5].
CNF, in contrast, increases the polymerization of F-actin
at focal contacts of adjacent cells, induces the formation of
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Fig. 3 Effects on actin
filaments and intercellular
junctions of toxins
modifying the actin
cytoskeleton. 
(A) HeLa cells untreated
(control) and treated with
Clostridium perfringens
Iota toxin, Escherichia
coli CNF, C3 enzyme 
(a fusion Iota-C3 toxin
that only exhibits 
C3 enzymatic activity
was used to internalize
the C3 enzyme into cells),
Clostridium difficile
ToxB and Clostridium
sordellii LT (10–7 M),
were stained with Texas
red-phalloidin and
observed by confocal
microscopy. Polarized
CaCo-2 cells grown on
filters, untreated and
toxin-treated, were
stained with anti-ZO1
antibodies 
(B), and with 
anti-E-cadherin
antibodies 
(C) to detect tight and
intermediate junctions
respectively
A
B
C
actin stress fibers and significantly increases cell monolayer
permeability. Depolymerization and the polymerization of actin
and the subsequent reorganization of the actin cytoskeleton
alter intestinal barrier function [14].
Other effects Rho proteins are involved in cell morphology,
adhesion, motility, cytokinesis, contractile response, cell growth,
and apoptosis and participate in many functions in the body
such as tissue organization, inflammatory cell migration and
tumor cell invasion [31]. These functions may be altered by
toxins modifying actin and Rho proteins.
Rho is important in integrin-clustering and controls cell
adhesion mediated by integrin. Aggregation and adhesion of
lymphocytes to extracellular matrix can be blocked by C3 [28]. 
The signaling of various hormones, neurotransmitters and
growth factors involves the stimulation of phospholipase D
(PLD), hydrolyzing the major membrane phospholipid,
phosphatidyl choline, to produce phosphatidic acid and choline,
which are involved in various physiological processes such as
cell growth, differentiation, and membrane trafficking. Ral has
been found to have a pivotal role in the stimulation of PLD by
phorbol ester, and large clostridial toxins that glucosylate Ral
block PLD activation and subsequent signaling [51]. Activation
of PLD may also result from the stimulation of the muscarinic
acetylcholine receptor. The signaling pathway involves Rho
and an increase in of PIP2 and may be blocked by ToxB and
C3 [49, 50].
Compelling data have shown that the actin cytoskeleton and
small GTPases from the Rho family are involved in endocytosis
and exocytosis. Therefore, cortical actin, trimeric G proteins
and Rho are involved in exocytosis in chromaffin cells. Iota
toxin and C3 have been used as tools to explore exocytosis
regulation in these cells [13]. It has been shown that Rho and
Rac inhibit transferrin-receptor-mediated endocytosis [25].
Lamellipodia and membrane ruffling controlled by Rac and
Rho are involved in endocytosis and bacterial entry into cells.
CNF induces membrane ruffles and increases bacterial uptake
by endocytosis [7]. Shigella invasion is mediated by Rho-
dependent membrane ruffling and can be blocked by C3 and
ToxB [1]. 
In addition, Rac regulates NADPH oxidase complex
formation and the subsequent production of superoxide in
neutrophils and monocytes. This function can be altered by
toxin inactivation of small G-proteins [29].
Concluding remarks The production of toxins is a powerful
bacteria-host interaction. The actin cytoskeleton and Rho
proteins, which precisely control actin polymerization, are
involved in many cell functions and are crucial targets for toxins. 
Bacterial toxins acting on the cytoskeleton dramatically
disturb cell morphology, intercellular junctions, the
permeability of epithelia and endothelia and functions
dependent on actin. They are involved in severe
gastrointestinal diseases and gangrene. Toxins are also
valuable tools for cell biology and treatment. Toxins that
recognize specific regulatory molecules of the Rho-Ras family
are powerful reagents for investigating the signaling pathways
dependent on these proteins. As Ras and Rho have been
implicated in cancer, toxins that specifically inactivate these
targets could be useful as antitumor agents. Toxins can
efficiently enter cells and could be useful to internalize
heterologous proteins or therapeutic compounds. In this
respect, binary toxins, the functional domains of which are
on separate proteins, are an attractive model ([2], and
manuscript submitted).
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